Tirzepatide · GLP-1 + GIP · Physician-managed
Tirzepatide: dual-action, physician-managed.
The molecule behind Mounjaro® and Zepbound® targets two receptors — GLP-1 and GIP — for some of the strongest results in the class. Injectable or oral, with a licensed provider managing every step.
Targets GLP-1 and GIP — appetite, gastric emptying, and insulin sensitivity together.
No insurance required. HSA/FSA accepted, US-based pharmacies, care 7 days a week.
What it is
Two receptors. One protocol.
Tirzepatide is a dual GIP and GLP-1 receptor agonist — the active molecule in Mounjaro® and Zepbound®. Where semaglutide acts on one hunger-and-metabolism pathway, tirzepatide acts on two.
That dual action is why tirzepatide has produced some of the strongest weight-loss results ever studied in the class — reduced hunger, slower gastric emptying, and improved insulin sensitivity working together.
More power makes management matter more, not less. The right candidate screening, a careful titration schedule, and side effects handled early are what separate lasting results from a rough few months — and that's what a vetted, licensed provider is for.
How it works
What dual-action actually means.
GLP-1 quiets hunger; GIP amplifies the metabolic effect. Together:
Reduces hunger
GLP-1 signaling tells the brain you're full — portions shrink without white-knuckling.
Slows gastric emptying
Meals last longer in the stomach, extending satiety between them.
Improves insulin sensitivity
The GIP pathway supports how your body handles glucose and stores energy.
Compounds the effect
The two pathways reinforce each other — the reason head-to-head results lead the class.
What to expect
Strong results — earned carefully.
Your provider starts low, titrates slowly, and stays with you — the dual mechanism rewards patience.
Free consult
Talk goals and history with a licensed provider — no charge, no obligation.
Start low
If approved, you begin at a low dose while your body adjusts.
Appetite shifts
Hunger and food noise quiet down as the dose titrates upward.
Steady progress
Monthly follow-ups, dose adjustments, and nutrition support to protect muscle.
Who it’s for
A provider decides if it's right for you.
Likely a fit
- BMI of 30+, or 27+ with a weight-related condition like type 2 diabetes or hypertension.
- You've plateaued on other approaches — including, for some patients, other GLP-1s.
- You want the strongest option in the class, managed by a physician.
Not right now
- Personal or family history of medullary thyroid carcinoma or MEN 2.
- Pregnant, breastfeeding, or planning pregnancy soon.
- History of pancreatitis or certain GI conditions — your provider will review.
Eligibility is determined by an independent licensed provider. GLP-1/GIP medications carry risks and contraindications; clinical details here are placeholders pending HRx review.
Getting started
From consult to your door, in four steps.
Take the assessment
Two minutes on your goals, history, and state — so we can match you well.
A provider reviews
An independent licensed provider evaluates whether tirzepatide is appropriate for you.
Approved & shipped
If approved, your medication ships from a licensed US pharmacy. You're never charged before approval.
Managed ongoing
Dose titration, side-effect support, and nutrition guidance — seven days a week.
Start here
Two minutes to find out if tirzepatide fits.
A licensed provider reviews your answers — you’re never charged until treatment is approved.